Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 03/02/22
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 05/31/22
End: 09/30/22
Due: 09/30/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Study of F61 Injection in Healthy Chinese Subjects | NCT05483504 | Wuhan Institute of Biological Products Co., Ltd | user2@example.com | None | 2022-08-31 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years | NCT05389137 | Wuhan Institute of Biological Products Co., Ltd | user2@example.com | None | 2022-03-02 | 2022-10-31 | 2023-10-31 | - | - | 2025-07-14 |
| A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19 | NCT05381519 | Wuhan Institute of Biological Products Co., Ltd | user2@example.com | None | 2022-05-31 | 2022-09-30 | 2023-09-30 | - | - | 2025-07-14 |